The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease
Open accessAbstract
Alzheimer's disease is the commonest dementia. One major characteristic of its pathology is accumulation of amyloid‐β (Aβ) as insoluble deposits in brain parenchyma and in blood vessel walls [cerebral amyloid angiopathy (CAA)]. The distribution of Aβ deposits in the basement membranes of cerebral capillaries and arteries corresponds to the perivascular drainage pathways by which interstitial fluid (ISF) and solutes are eliminated from the brain—effectively the lymphatic drainage of the brain. Theoretical models suggest that vessel pulsations supply the motive force for perivascular drainage of ISF and solutes. As arteries stiffen with age, the amplitude of pulsations is reduced and insoluble Aβ is deposited in ISF drainage pathways as CAA, thus, further impeding the drainage of soluble Aβ. Failure of perivascular drainage of Aβ and deposition of Aβ in the walls of arteries has two major consequences: (i) intracerebral hemorrhage associated with rupture of Aβ‐laden arteries in CAA; and (ii) Alzheimer's disease in which failure of elimination of ISF, Aβ and other soluble metabolites from the brain alters homeostasis and the neuronal environment resulting in cognitive decline and dementia. Therapeutic strategies that improve elimination of Aβ and other soluble metabolites from the brain may prevent cognitive decline in Alzheimer's disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413
Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report
Nicoll, J. A. R., Wilkinson, D., Holmes, C., Steart, P., Markham, H., & Weller, R. O. (2003) · Nature Medicine · doi:10.1038/nm840 · Cited by 1,397
Self-citation(2001) · The Lancet · doi:10.1016/s0140-6736(00)03589-3 · Cited by 1,338
Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980
Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
Abbott, N. J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.006 · Cited by 786
Research works printed but not linked: 81
- 10.1016/0014-4886(84)90192-4 · DOI
- 10.1111/j.1365-2990.1988.tb00862.x · DOI · Paper page
- 10.1148/radiology.217.3.r00dc42877 · DOI · Paper page
- 10.1016/j.jns.2007.01.013 · DOI
- 10.1093/jnen/59.4.308 · DOI
- Bergsneider M, 2001, Evolving concepts of Cerebrospinal Fluid, Neurosurg Clin N Am, 36, 631, 10.1016/S1042-3680(18)30021-4 · DOI
- 10.1111/j.1750-3639.1996.tb00793.x · DOI
- 10.1002/ana.410420116 · DOI
- 10.1152/ajpregu.1999.276.3.R818 · DOI
- 10.1111/j.1365-2990.2007.00926.x · DOI · Paper page
- 10.1002/1097-4547(20001101)62:3<451::AID-JNR15>3.0.CO;2-F · DOI
- 10.1016/j.neuron.2005.10.028 · DOI · Paper page
- 10.1016/0167-5699(92)90027-5 · DOI · Paper page
- Davson H, 1987, Physiology and Pathophysiology of the Cerebrospinal Fluid
- 10.1097/01.jnen.0000171644.00180.fc · DOI
- Ely M, 1996, Estimating the numbers and characteristics of elderly people with cognitive disability in local populations, Res Policy Plan, 14, 13
- 10.1017/CBO9780511526886 · DOI
- 10.1007/s004010000195 · DOI · Paper page
- 10.2353/ajpath.2007.070105 · DOI
- 10.1093/jnen/64.1.82 · DOI
- 10.1016/j.it.2006.11.004 · DOI · Paper page
- 10.1038/ng0106-11 · DOI
- 10.1038/nm0706-756 · DOI
- 10.1016/S0165-5728(99)00130-7 · DOI
- 10.1016/0165-5728(89)90136-7 · DOI · Paper page
- 10.1002/1096-9896(200106)194:2<262::AID-PATH882>3.0.CO;2-W · DOI
- 10.1111/j.1750-3639.2006.tb00560.x · DOI · Paper page
- 10.1111/j.1600-0447.1987.tb02906.x · DOI · Paper page
- 10.1111/j.1750-3639.2002.tb00451.x · DOI · Paper page
- 10.1111/j.1365-2990.1993.tb00476.x · DOI · Paper page
- 10.1385/JMN:24:1:167 · DOI
- 10.1080/13506120601116419 · DOI
- 10.1002/(SICI)1096-9896(199901)187:2<259::AID-PATH212>3.0.CO;2-H · DOI
- 10.1111/j.1365-2990.2006.00747.x · DOI
- 10.1016/S0896-6273(03)00787-6 · DOI · Paper page
- 10.1111/j.1750-3639.2006.tb00562.x · DOI
- 10.1016/S0002-9440(10)65184-X · DOI · Paper page
- 10.1111/j.1365-2990.1984.tb00351.x · DOI · Paper page
- 10.1097/00005072-199907000-00005 · DOI · Paper page
- 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M · doi:10.1002/1531-8249(199912)46:6<860::aid-ana8>3.0.co;2-m
- 10.1097/01.jnen.0000240463.87886.9a · DOI
- 10.1111/j.1460-9568.2004.03534.x · DOI
- Nagasawa S, 1979, Mechanical properties of human cerebral arteries. Part 1: effects of age and vascular smooth muscle activation, Surg Neurol, 12, 297
- 10.1016/S0014-4886(03)00315-7 · DOI
- 10.3171/jns.1988.69.2.0276 · DOI · Paper page
- 10.1097/01.jnen.0000240466.10758.ce · DOI · Paper page
- 10.1016/j.neurobiolaging.2004.02.003 · DOI · Paper page
- 10.1111/j.1750-3639.2006.tb00561.x · DOI
- 10.1002/(SICI)1096-9896(199708)182:4<457::AID-PATH870>3.0.CO;2-Y · DOI
- 10.1046/j.1365-2990.2003.00424.x · DOI · Paper page
- 10.1111/j.1750-3639.1996.tb00798.x · DOI
- 10.1093/jnen/62.9.885 · DOI · Paper page
- 10.1007/BF03402043 · DOI · Paper page
- 10.1002/ana.20596 · DOI · Paper page
- 10.1016/S0002-9440(10)63824-2 · DOI · Paper page
- 10.1038/nm1635 · DOI · Paper page
- Salzman KL, 2005, Giant Tumefactive Perivascular Spaces, Am J Neuroradiol, 26, 298
- 10.1007/BF02890989 · DOI · Paper page
- 10.1152/physrev.2001.81.2.741 · DOI · Paper page
- 10.3233/JAD-2006-9S319 · DOI
- 10.1093/brain/awm156 · DOI · Paper page
- Subash M, 2003, Cerebral amyloid angiopathy: differential preservation of endothelial cell basement membranes, Neuropath Appl Neurobiol, 29, 184
- 10.1073/pnas.0408235102 · DOI · Paper page
- 10.1152/ajprenal.1984.246.6.F835 · DOI · Paper page
- 10.1097/RCT.0b013e318038fc5d · DOI
- 10.1016/S0140-6736(03)13555-6 · DOI · Paper page
- 10.1016/S0002-9440(10)64644-5 · DOI · Paper page
- 10.1007/s004010100414 · DOI
- 10.1042/BST0350416 · DOI
- Weller RO, 1995, Gray's Anatomy, 1202
- 10.1016/S1286-0115(05)83235-7 · DOI · Paper page
- 10.1002/ana.20622 · DOI
- 10.1179/016164103101202057 · DOI
- 10.1093/brain/92.4.819 · DOI
- 10.1016/S0002-9440(10)65616-7 · DOI · Paper page
- 10.1186/1742-2094-1-24 · DOI
- 10.1007/BF00296738 · DOI · Paper page
- 10.1111/j.1749-6632.2002.tb04844.x · DOI
- 10.1016/S0002-9440(10)64713-X · DOI · Paper page
- 10.1007/s004010050935 · DOI
- 10.1111/j.1750-3639.2006.tb00559.x · DOI · Paper page
Cited by
Iliff, J. J., Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., Vates, G. E., Deane, R., Goldman, S. A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003748 · Cited by 5,824
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
The glymphatic system: a beginner's guide
Jessen, N. A., Munk, A. S. F., Lundgaard, I., & Nedergaard, M. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1581-6 · Cited by 2,075
Clearance systems in the brain—implications for Alzheimer disease
Tarasoff-Conway, J. M., Carare, R. O., Osorio, R. S., Glodzik, L., Butler, T., Fieremans, E., Axel, L., Rusinek, H., Nicholson, C., Zlokovic, B. V., et al. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.119 · Cited by 1,678
Self-citationApolipoprotein E and Alzheimer disease: pathobiology and targeting strategies
Yamazaki, Y., Zhao, N., Caulfield, T. R., Liu, C.-C., & Bu, G. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0228-7 · Cited by 1,425
Metadata
- Authors
- Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O.
- Venue
- Brain Pathology
- Publisher
- Wiley
- Published
- 2008-01-03
- Volume
- 18
- Issue
- 2
- Pages
- 253-266
- ISSN
- 1015-6305 (ISSN-L)
- 1750-3639
- OpenAlex
- W2143238511
- Cited by
- 681
- References
- 25
- FWCI
- 13.08
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease. https://app.cochat.ai/papers/10.1111/j.1750-3639.2008.00133.x
- The paper
- Weller, R. O., Subash, M., Preston, S. D., Mazanti, I., & Carare, R. O. (2008). SYMPOSIUM: Clearance of Aβ from the Brain in Alzheimer's Disease: Perivascular Drainage of Amyloid‐β Peptides from the Brain and Its Failure in Cerebral Amyloid Angiopathy and Alzheimer's Disease. Brain Pathology. https://doi.org/10.1111/j.1750-3639.2008.00133.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.